Waters Corporation (WAT) Financial Analysis & Valuation | Quarter Chart
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spe... more
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia,... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $41.62B | Exchange | NYSE |
| Sector | Healthcare | Industry | Medical - Diagnostics & Research |
| Country | US | CEO | Udit Batra |
| IPO Date | 1995-11-17 | CAGR | 7.8% |
| Employees | 7,900 | Website | www.waters.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.05% | Total Yield | 0.05% |
WAT chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $57.44B | P/E | 30.99 | Forward P/E | 25.62 | PEG | — |
| P/S | 16.54 | P/B | 7.62 | P/CF | 210.75 | P/FCF | 193.68 |
| Sales | $4.64B | Sales 1Y | 52.47% | Sales 3Y | 55.21% | Sales 5Y | 73.9% |
| EPS | $13.68 | EPS 1Y | -63.84% | EPS 3Y | -64.64% | EPS 5Y | -62.1% |
| Sales QoQ | 29.83% | EPS QoQ | 59.77% | Sales QoQ Avg | 21.5% | EPS QoQ Avg | -2.82% |
| Gross Margin | 50.78% | Operating Margin | 7.96% | Profit Margin | 3.58% | ROCE | 1.49% |
| ROA | 1% | ROE | 2% | Altman Z Score | 2.94 | Piotroski Score | 4 |
| Current Ratio | — | Quick Ratio | — | Cash Ratio | — | Op. CF Ratio | — |
| Debt/Equity | 0.33 | Debt/Assets | 0.21 | Lt Debt/Equity | 0.33 | Lt Debt/Cap. | 0.25 |
| Intrst Cov. | 2.67 | Inventory Turnover | 1.66 | Asset Turnover | 0.19 | Receivables Turnover | 2.34 |
| Enterprise Value | $57.44B | P/E Ratio | 30.99 |
| Forward P/E | 25.62 | PEG Ratio | — |
| P/S Ratio | 16.54 | P/B Ratio | 7.62 |
| P/CF Ratio | 210.75 | P/FCF Ratio | 193.68 |
| EPS | $13.68 | EPS Growth 1Y | -63.84% |
| EPS Growth 3Y | -64.64% | EPS Growth 5Y | -62.1% |
| Revenue Growth 1Y | 52.47% | Gross Margin | 50.78% |
| Operating Margin | 7.96% | Profit Margin | 3.58% |
| ROE | 2% | ROA | 1% |
| ROCE | 1.49% | Current Ratio | — |
| Quick Ratio | — | Cash Ratio | — |
| Debt/Equity | 0.33 | Interest Coverage | 2.67 |
| Altman Z Score | 2.94 | Piotroski Score | 4 |
Waters Corporation (WAT) valuation & financials
Waters Corporation (WAT) has a market capitalization of $41.62B and trades at a price-to-earnings ratio of 31.0. It operates in the Healthcare sector (Medical - Diagnostics & Research).
Waters Corporation's revenue grew +52.5% over the last year.
Waters Corporation's next earnings report is scheduled for November 3, 2026 before market open (provider scheduled date); analysts estimate EPS of $4.01. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)